Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.

Derkow K, Bauer JM, Hecker M, Paap BK, Thamilarasan M, Koczan D, Schott E, Deuschle K, Bellmann-Strobl J, Paul F, Zettl UK, Ruprecht K, Lehnardt S.

PLoS One. 2013 Aug 12;8(8):e70626. doi: 10.1371/journal.pone.0070626. eCollection 2013.

2.

Impaired toll-like receptor 8 signaling in multiple sclerosis.

Johnson TP, Tyagi R, Patel K, Schiess N, Calabresi PA, Nath A.

J Neuroinflammation. 2013 Jun 21;10:74. doi: 10.1186/1742-2094-10-74.

3.

Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.

Münzel EJ, Wimperis JZ, Williams A.

BMJ Case Rep. 2013 Feb 14;2013. pii: bcr2012007936. doi: 10.1136/bcr-2012-007936.

4.

Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins.

Feng X, Han D, Kilaru BK, Franek BS, Niewold TB, Reder AT.

Arch Neurol. 2012 Oct;69(10):1303-9.

5.

The role of cell type-specific responses in IFN-β therapy of multiple sclerosis.

Zula JA, Green HC, Ransohoff RM, Rudick RA, Stark GR, van Boxel-Dezaire AH.

Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19689-94. doi: 10.1073/pnas.1117347108. Epub 2011 Nov 21.

6.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk